<DOC>
	<DOCNO>NCT01907490</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability single application Ha44 Gel 0.74 % w/v treatment head louse maximal use condition . Secondary objective evaluate pharmacokinetics Ha44 benzyl alcohol ( contain Ha44 vehicle ) maximal use condition .</brief_summary>
	<brief_title>Safety PK Study Ha44 Gel Under Maximal Use Conditions Treatment Head Lice Infestation</brief_title>
	<detailed_description>This open-label safety pharmacokinetic ( PK ) study involve single application Ha44 Gel 0.74 % administer maximal use condition . All participant must active head louse infestation ( least 3 live louse ) 6 month 17 year age . The study enroll approximately 36 pediatric subject age 6 month 17 year . Pediatric PK sample collect 0 ( predose ) , 30 60 min 2 8 hr time point . More one household member active louse infestation may participate study . Eligible subject consent screen study eligibility Day 0 ( Visit 1 ) . All subject return study site three follow-up clinic visit Days 1 , 7 14 . The maximum study duration subject 16 day .</detailed_description>
	<mesh_term>Lice Infestations</mesh_term>
	<mesh_term>Parasitic Diseases</mesh_term>
	<mesh_term>Mite Infestations</mesh_term>
	<criteria>1 . Male female 2 . 6 month 17 year age 3 . Be good health , determine medical history physical examination 4 . Has active head louse infestation screen determine experienced evaluator . An active infestation define presence least 3 live louse . 5 . Female subject must : Of nonchildbearing potential ( history menstrual period , posthysterectomy , postmenopausal least 2 year ) OR , If childbearing potential , must negative urine pregnancy test prior treatment agree use highly effective method contraception Day 0 Day 14 visit . Acceptable method contraception include abstinence , vasectomized partner , tubal ligation , combine oral hormonal contraceptive , contraceptive injection , contraceptive patch , IUD . If hormonal contraception method , subject must stable dose least 3 month . 6 . The parent/guardian agree allow serial blood sample collect subject PK analysis study . 7 . Has sign inform consent and/or assent form ( ICF ) . 1 . Has condition illness , opinion Investigator , may interfere study result . 2 . Has current dermatological disease inflammation face , scalp , ear , neck back , include eczema , atopic dermatitis , alopecia , psoriasis chronic skin disease , opinion Investigator , would interfere safety PK evaluation . 3 . Had prior reaction product contain piperonyl butoxide , pyrethrin , pyrethrum extract . 4 . Has use hormonal contraception le 3 month . 5 . Is pregnant currently nurse . 6 . Receiving systemic topical medication , opinion Investigator , may interfere study result . 7 . Has receive investigational agent within 30 day prior Day 0 .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Topical treatment Head Lice Infestation</keyword>
</DOC>